Skip Navigation

Improving delivery of malaria treatments

3 March 2014

Professor David Schellenberg, Director of the ACT Consortium, discusses their work to improve the way artemisinin-based combination therapies are used to treat malaria, as well as the challenges they face working across 10 different countries.

 

International Innovation, a leading global dissemination resource for the wider scientific, technology and research communities, published the feature about the work of the ACT Consortium.

Research Themes


comments powered by Disqus